LZP

4,4'-piperazine-1,4-diylbis{1-[3-(benzyloxy)phenyl]-4-oxobutane-1,3-dione}

Created:	2008-09-04
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where LZP is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	82
Chiral Atom Count	0
Bond Count	86
Aromatic Bond Count	24

2D diagram of LZP

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4,4'-piperazine-1,4-diylbis{1-[3-(benzyloxy)phenyl]-4-oxobutane-1,3-dione}
Systematic Name (OpenEye OEToolkits)	1-[4-[2,4-dioxo-4-(3-phenylmethoxyphenyl)butanoyl]piperazin-1-yl]-4-(3-phenylmethoxyphenyl)butane-1,2,4-trione
Formula	C₃₈ H₃₄ N₂ O₈
Molecular Weight	646.685
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=C(C(=O)CC(=O)c2cccc(OCc1ccccc1)c2)N5CCN(C(=O)C(=O)CC(=O)c4cccc(OCc3ccccc3)c4)CC5
SMILES	CACTVS	3.341	O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)N3CCN(CC3)C(=O)C(=O)CC(=O)c4cccc(OCc5ccccc5)c4
SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)COc2cccc(c2)C(=O)CC(=O)C(=O)N3CCN(CC3)C(=O)C(=O)CC(=O)c4cccc(c4)OCc5ccccc5
Canonical SMILES	CACTVS	3.341	O=C(CC(=O)c1cccc(OCc2ccccc2)c1)C(=O)N3CCN(CC3)C(=O)C(=O)CC(=O)c4cccc(OCc5ccccc5)c4
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)COc2cccc(c2)C(=O)CC(=O)C(=O)N3CCN(CC3)C(=O)C(=O)CC(=O)c4cccc(c4)OCc5ccccc5
InChI	InChI	1.03	InChI=1S/C38H34N2O8/c41-33(29-13-7-15-31(21-29)47-25-27-9-3-1-4-10-27)23-35(43)37(45)39-17-19-40(20-18-39)38(46)36(44)24-34(42)30-14-8-16-32(22-30)48-26-28-11-5-2-6-12-28/h1-16,21-22H,17-20,23-26H2
InChIKey	InChI	1.03	WITKJXOKUUWDOW-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	42628066
ChEMBL	CHEMBL443890

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.